LONDON, England—A new analysis is emphasizing the prognostic significance of residual tricuspid regurgitation (TR) following mitral valve-in-valve procedures, with investigators showing that those ...

Nixon, an Intuitive veteran, said Capstan is focused primarily on mitral and tricuspid treatment, where it sees “significant ...

Mitral regurgitation — blood flowing the wrong ... Until very recently, imaging tools for right-sided heart diseases, such as tricuspid valve regurgitation, were not as well developed as those ...

Edwards submitted a request for a national coverage determination in February, after receiving FDA approval for its Evoque ...

Mitral regurgitation is when the faulty valve allows ... S1 happens when two of the heart's valves, the mitral and tricuspid valves, close. These valves close in systole when the heart pumps ...

Patients enrolled in the TRISCEND II trial had at least severe tricuspid regurgitation (TR ... transcatheter mitral and tricuspid therapies. “We are building a portfolio of transcatheter ...

The most commonly encountered valve conditions were tricuspid regurgitation (13.8%), mitral regurgitation (12.8%), and aortic ...

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR ...

and Transcatheter Mitral and Tricuspid Therapies (TMTT), the continued long-term performance of Surgical, and future opportunities with Structural Heart Failure and Aortic Regurgitation (AR).

He also pointed to new areas like Structural Heart Failure and Aortic Regurgitation (AR ... The Transcatheter Mitral and Tricuspid Therapies (TMTT) segment is forecasted to grow by 50% to 60% ...